Terms ending in 2038
Every in-force patent on BioAtla Inc.'s record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,773,509 | Conditionally Active Polypeptides and Methods of Generating Them In force · High confidence | BioAtla, Inc. | In force | High confidence | |
| US 11,293,929 | Proteins Targeting Orthologs In force · High confidence | BioAtla, Inc. | In force | High confidence | |
| US 11,584,927 | Conditionally Active Chimeric Antigen Receptors for Modified T-Cells In force · Low confidence | BioAtla, Inc. | In force | Low confidence |
3 of 3 patents shown. Soonest term end first, then patent number.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.